Baraliakos, X., Witte, T., De Clerck, L., Frediani, B., Collantes-Estévez, E., Katsifis, G., . . . Goodson, N. (2020). Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe. Rheumatology (Oxford).
Citação norma ChicagoBaraliakos, Xenofon, et al. "Effectiveness and Safety of 12-month Certolizumab Pegol Treatment for Axial Spondyloarthritis in Real-world Clinical Practice in Europe." Rheumatology (Oxford) 2020.
MLA CitationBaraliakos, Xenofon, et al. "Effectiveness and Safety of 12-month Certolizumab Pegol Treatment for Axial Spondyloarthritis in Real-world Clinical Practice in Europe." Rheumatology (Oxford) 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.